Page 4 - Exact Sciences News Today

Xponance Inc. decreased its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,405 shares of the medical research company’s stock after selling 668 shares during the […]

Exact Sciences Corp. (EXAS) just unveiled an update. Dr. Freda Lewis-Hall, a board member of Exact Sciences Corporation, plans to retire immediatel...

New blood tests measure “signals” in the blood to help detect cancer. Experts say more study is needed to determine if the new tests save lives

The FDA encourages collection and reporting of patient-reported outcomes (PROs) in clinical trials, but a substantial proportion of applications seeking product approval lack these data. Assessment of patient-reported outcomes in clinical trials is on the rise, but they frequently are absent from requests for FDA drug approvals.

In this article, we discuss the 10 best performing biotech ETFs in 2024.

Hussman Strategic Advisors Inc. grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 400.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,500 shares of the medical research company’s stock after buying an additional 25,200 shares […]

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors purchased 16,937 call options on the company. This is an increase of 291% compared to the average volume of 4,328 call options. Insider Activity at Exact Sciences In other Exact Sciences news, CEO Kevin T. […]

The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along...

The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.